Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 6

1.

Taking the brakes off telomerase.

Naxerova K, Elledge SJ.

Elife. 2015 Jul 21;4. doi: 10.7554/eLife.09519.

2.

Hypermutable DNA chronicles the evolution of human colon cancer.

Naxerova K, Brachtel E, Salk JJ, Seese AM, Power K, Abbasi B, Snuderl M, Chiang S, Kasif S, Jain RK.

Proc Natl Acad Sci U S A. 2014 May 6;111(18):E1889-98. doi: 10.1073/pnas.1400179111. Epub 2014 Apr 21.

3.

Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors.

Rogers MS, Novak K, Zurakowski D, Cryan LM, Blois A, Lifshits E, Bø TH, Oyan AM, Bender ER, Lampa M, Kang SY, Naxerova K, Kalland KH, Straume O, Akslen LA, Watnick RS, Folkman J, Naumov GN.

Mol Cancer Res. 2014 May;12(5):754-64. doi: 10.1158/1541-7786.MCR-13-0532-T. Epub 2014 Feb 26.

4.

TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma.

Liu J, Liao S, Diop-Frimpong B, Chen W, Goel S, Naxerova K, Ancukiewicz M, Boucher Y, Jain RK, Xu L.

Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16618-23. doi: 10.1073/pnas.1117610109. Epub 2012 Sep 20.

5.

PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer.

Liu J, Liao S, Huang Y, Samuel R, Shi T, Naxerova K, Huang P, Kamoun W, Jain RK, Fukumura D, Xu L.

Clin Cancer Res. 2011 Jun 1;17(11):3638-48. doi: 10.1158/1078-0432.CCR-10-2456. Epub 2011 Apr 1.

6.

Analysis of gene expression in a developmental context emphasizes distinct biological leitmotifs in human cancers.

Naxerova K, Bult CJ, Peaston A, Fancher K, Knowles BB, Kasif S, Kohane IS.

Genome Biol. 2008;9(7):R108. doi: 10.1186/gb-2008-9-7-r108. Epub 2008 Jul 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk